In short
Sodium Chloride appears in many clinical trials as a control, placebo, or comparison fluid, and sometimes as part of the study treatment plan. This article looks at what these trials are studying, who they include, which phases they are in, and what outcomes they measure. The focus is on research questions, not on the substance itself.
Key points
- Sodium Chloride is used in many trials as a placebo, control, or comparison treatment. The studies cover a wide range of conditions, including pain, infection, surgery, kidney disease, heart disease, and brain injury. Most trials are Phase 2 or Phase 3, with some Phase 4 and early Phase 1 studies. Target groups include adults, children, newborns, healthy volunteers, and critically ill patients. The main outcomes often measure symptom relief, recovery, survival, safety, or lab and imaging results. Overall, these trials use Sodium Chloride to help test whether the study treatment works better than a neutral comparison.
Overview of Sodium Chloride in trials
Sodium Chloride appears in many studies as a placebo, a control, or a comparison fluid. In these trials, the main question is usually about another treatment, procedure, or care strategy, not Sodium Chloride itself.
The trial topics are very broad and include surgery, infection, pain, kidney disease, heart disease, lung disease, brain injury, and allergy testing. Some studies also use Sodium Chloride as part of the study process in early safety research or in procedure-based trials.
What these trials are testing
Many trials compare an active treatment against Sodium Chloride to see if the active treatment improves a health outcome. Examples include pain control after surgery, infection prevention, recovery after critical illness, and changes in organ function.
- Pain and recovery studies look at things like opioid use, pain scores, mobility, and quality of recovery after surgery.
- Infection and inflammation studies look at outcomes such as mortality, infection rates, inflammatory markers, and time to clinical recovery.
- Organ function studies look at kidney, lung, heart, or brain outcomes, such as creatinine, forced vital capacity, ejection fraction, or neurological recovery.
- Procedure studies compare a treatment or technique with a placebo or sham procedure to see if it improves comfort, safety, or success of the procedure.
Who is included
The target populations are very different from one trial to another. Some studies include adults with chronic diseases such as cirrhosis, cancer, autoimmune disease, chronic pain, or kidney failure.
Other studies focus on special groups such as children, newborns, adolescents, older adults, healthy volunteers, or patients in the intensive care unit (ICU). Some trials also focus on people after surgery, such as cardiac surgery, hip surgery, colon surgery, or brain surgery.
Several studies are aimed at very specific groups, such as people with severe hyponatremia, sickle cell disease, hidradenitis suppurativa, thyroid eye disease, or autism spectrum disorder.
Trial phases and study size
The collection includes a wide mix of trial phases, with many studies in Phase 3 and several in Phase 2. There are also smaller early studies in Phase 1 or Phase 1/2, and some low-intervention studies that mainly compare standard care or fluids.
Enrollment ranges from very small pilot studies with fewer than 20 people to large multicenter trials with thousands of participants. This shows that Sodium Chloride is used across both early research and larger confirmatory studies.
Main outcomes being measured
The primary outcomes depend on the condition being studied and the goal of the trial. Many outcomes are patient-centered, such as pain relief, breathing ability, mobility, recovery scores, or survival.
- Pain scores are used in many trials, often measured with scales such as the Numeric Rating Scale (NRS) or Visual Analog Scale (VAS).
- Recovery and function outcomes include walking, mobility scores, quality of recovery questionnaires, and disability scales.
- Organ injury or function outcomes include kidney injury, lung function, heart function, and brain injury markers.
- Safety outcomes often include adverse events, serious adverse events, laboratory tests, and vital signs.
Some studies also use imaging tests, blood markers, or disease-specific scales to measure change over time.
Selected important trials
The LOTUS trial studies chronic hemodialysis patients and looks at muscle protein synthesis and hemodynamic effects during a one-week treatment period. Its main outcome is the difference in myofibrillar fractional synthetic rate, which is a measure of muscle protein building.
The LIVER AKI trial compares human albumin with Sodium Chloride 0.9% in patients with decompensated cirrhosis and acute kidney injury, and it measures kidney recovery without the need for renal replacement therapy. This is a Phase 3 study with 114 participants.
The FORE-PAIN trial studies acute traumatic pain in the prehospital setting and compares several pain treatments against controls, including Sodium Chloride used intranasally and intravenously. Its main outcome is the change in pain score 10 minutes after treatment.
The CAT-Trial studies painful diabetic neuropathy and measures average pain intensity over 24 weeks. Sodium Chloride is used as the placebo comparison in this Phase 2 study.
The TICH-3 trial studies tranexamic acid in stroke caused by intracerebral haemorrhage and uses Sodium Chloride Injection as the comparison treatment. The main outcome is early death within 7 days after the bleed.
The LOTUS, LIVER AKI, and TICH-3 studies show how Sodium Chloride is often used to help compare a new treatment against a neutral control in serious hospital conditions.
What this means for patients
If you see Sodium Chloride in a trial record, it often means the study is comparing a new treatment against a standard neutral option. This makes it easier to know whether the active treatment really helps.
These trials do not all study the same illness, so the meaning of participation depends on the condition, age group, and treatment plan in that specific study. Some trials are short and focus on immediate outcomes, while others follow people for months or even years.